| 001 | 54704 | ||
| 005 | 20200423204411.0 | ||
| 024 | 7 | _ | |a pmid:16497506 |2 pmid |
| 024 | 7 | _ | |a 10.1016/j.apradiso.2005.12.020 |2 DOI |
| 024 | 7 | _ | |a WOS:000237196400013 |2 WOS |
| 024 | 7 | _ | |a 2128/413 |2 Handle |
| 037 | _ | _ | |a PreJuSER-54704 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 530 |
| 084 | _ | _ | |2 WoS |a Chemistry, Inorganic & Nuclear |
| 084 | _ | _ | |2 WoS |a Nuclear Science & Technology |
| 084 | _ | _ | |2 WoS |a Radiology, Nuclear Medicine & Medical Imaging |
| 100 | 1 | _ | |a Al-Abyad, M. |b 0 |0 P:(DE-HGF)0 |
| 245 | _ | _ | |a Nuclear data for production of the therapeutic radionuclides 32P, 64Cu, 67Cu, 89Sr, 90Y and 153Sm via the (n,p) reaction: Evaluation of excitation function and its validation via integral cross-section measurement using a 14 MeV d(Be) neutron source |
| 260 | _ | _ | |a Amsterdam [u.a.] |b Elsevier Science |c 2006 |
| 300 | _ | _ | |a 717 - 724 |
| 336 | 7 | _ | |a Journal Article |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a article |2 DRIVER |
| 440 | _ | 0 | |a Applied Radiation and Isotopes |x 0969-8043 |0 563 |v 64 |
| 500 | _ | _ | |a Record converted from VDB: 12.11.2012 |
| 520 | _ | _ | |a Nuclear data for production of the therapeutic radionuclides 32P, 64Cu, 67Cu, 89Sr, 90Y and 153Sm via (n,p) reactions on the target nuclei 32S, 64Zn, 67Zn, 89Y, (90)Zr and 153Eu, respectively, are discussed. The available information on each excitation function was analysed. From the recommended data set for each reaction the average integrated cross section for a standard 14 MeV d(Be) neutron field was deduced. The spectrum-averaged cross section was also measured experimentally. A comparison of the integrated value with the integral measurement served to validate the excitation function within about 15%. A fast neutron source appears to be much more effective than a fission reactor for production of the above-mentioned radionuclides in a no-carrier-added form via the (n,p) process. In particular, the possibility of production of high specific activity 153Sm is discussed. |
| 536 | _ | _ | |a Funktion und Dysfunktion des Nervensystems |c P33 |2 G:(DE-HGF) |0 G:(DE-Juel1)FUEK409 |x 0 |
| 588 | _ | _ | |a Dataset connected to Web of Science, Pubmed |
| 650 | _ | 2 | |2 MeSH |a Neutrons |
| 650 | _ | 2 | |2 MeSH |a Radioisotopes: chemistry |
| 650 | _ | 2 | |2 MeSH |a Radiopharmaceuticals: chemistry |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a Radioisotopes |
| 650 | _ | 7 | |0 0 |2 NLM Chemicals |a Radiopharmaceuticals |
| 650 | _ | 7 | |a J |2 WoSType |
| 653 | 2 | 0 | |2 Author |a therapeutic radionuclide |
| 653 | 2 | 0 | |2 Author |a (n,p) reaction |
| 653 | 2 | 0 | |2 Author |a excitation function |
| 653 | 2 | 0 | |2 Author |a integral test |
| 653 | 2 | 0 | |2 Author |a 14MeV d(Be) neutron source |
| 653 | 2 | 0 | |2 Author |a nuclear model calculation |
| 700 | 1 | _ | |a Spahn, I. |b 1 |u FZJ |0 P:(DE-Juel1)VDB43831 |
| 700 | 1 | _ | |a Sudár, S. |b 2 |u FZJ |0 P:(DE-Juel1)VDB21537 |
| 700 | 1 | _ | |a Morsy, M. |b 3 |0 P:(DE-HGF)0 |
| 700 | 1 | _ | |a Comsan, M. N. H. |b 4 |0 P:(DE-HGF)0 |
| 700 | 1 | _ | |a Csikai, J. |b 5 |0 P:(DE-HGF)0 |
| 700 | 1 | _ | |a Qaim, S. M. |b 6 |u FZJ |0 P:(DE-Juel1)VDB1300 |
| 700 | 1 | _ | |a Coenen, H. H. |b 7 |u FZJ |0 P:(DE-Juel1)131816 |
| 773 | _ | _ | |a 10.1016/j.apradiso.2005.12.020 |g Vol. 64, p. 717 - 724 |p 717 - 724 |q 64<717 - 724 |0 PERI:(DE-600)1499873-7 |t Applied radiation and isotopes |v 64 |y 2006 |x 0969-8043 |
| 856 | 7 | _ | |u http://dx.doi.org/10.1016/j.apradiso.2005.12.020 |u http://hdl.handle.net/2128/413 |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/54704/files/Elsevier_INC_AlAbyadNucl.pdf |y OpenAccess |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/54704/files/Elsevier_INC_AlAbyadNucl.jpg?subformat=icon-1440 |x icon-1440 |y OpenAccess |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/54704/files/Elsevier_INC_AlAbyadNucl.jpg?subformat=icon-180 |x icon-180 |y OpenAccess |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/54704/files/Elsevier_INC_AlAbyadNucl.jpg?subformat=icon-640 |x icon-640 |y OpenAccess |
| 909 | C | O | |o oai:juser.fz-juelich.de:54704 |p openaire |p open_access |p driver |p VDB |p dnbdelivery |
| 913 | 1 | _ | |k P33 |v Funktion und Dysfunktion des Nervensystems |l Funktion und Dysfunktion des Nervensystems |b Gesundheit |0 G:(DE-Juel1)FUEK409 |x 0 |
| 914 | 1 | _ | |y 2006 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0010 |a JCR/ISI refereed |
| 915 | _ | _ | |2 StatID |0 StatID:(DE-HGF)0510 |a OpenAccess |
| 920 | 1 | _ | |k INC |l Institut für Nuklearchemie |d 31.12.2006 |g INC |0 I:(DE-Juel1)VDB53 |x 0 |
| 970 | _ | _ | |a VDB:(DE-Juel1)85555 |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a JUWEL |
| 980 | _ | _ | |a ConvertedRecord |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a I:(DE-Juel1)INM-5-20090406 |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a FullTexts |
| 980 | 1 | _ | |a FullTexts |
| 981 | _ | _ | |a I:(DE-Juel1)INM-5-20090406 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|
Gast ::